Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 3/2021

Open Access 01-08-2021 | Obesity | Original Article

How reliable is BMI? Bioimpedance analysis of body composition in underweight, normal weight, overweight, and obese women

Authors: Agata Lebiedowska, Magdalena Hartman-Petrycka, Barbara Błońska-Fajfrowska

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2021

Login to get access

Abstract

Background

The human body consists of water, proteins, lipids, carbohydrates, and minerals that build cells, tissues, and organs. In healthy people, the content of these molecules remains nearly constant. The body mass index (BMI) is commonly used to classify abnormal body composition among adults. According to the WHO, a high BMI is a major risk factor for many diseases. Bioelectrical impedance analysis is a commonly used method for assessing body composition in clinical practice and medical research.

Aims

The aim of this study was to identify the advantages and disadvantages of using BMI in diagnosis of underweight, overweight, and obesity, by comparing the value of the index with the values of body composition analysis parameters.

Methods

A total of 267 healthy women 18 to 35 years of age participated in this study. Bioelectrical impedance analysis was performed on all participants at the beginning of the experiment with an InBodyS10 device.

Results

In the BMI categories of overweight and obese, only women with excessive BFM were measured with BIA. The BMI category of normal body weight, apart from women with normal body composition, includes people with both deficient and excess body components, e.g., body fat or lean body mass. The BMI category of underweight includes women with different body compositions as well as people with excessive fat content.

Conclusions

The BMI is useful to provide a warning of excessive fat content in overweight and obese women, whereas among normal weight and underweight women, it may mask various types of body composition defects.
Appendix
Available only for authorised users
Literature
3.
go back to reference Bolanowski M, Zadrożna-Śliwka B, Zatońska K (2005) Body composition studies — methods and possible application in hormonal disorders. Endocrinol Obes 1(1):20–25 Bolanowski M, Zadrożna-Śliwka B, Zatońska K (2005) Body composition studies — methods and possible application in hormonal disorders. Endocrinol Obes 1(1):20–25
4.
go back to reference World Health Organisation (2016) Obesity and overweight. Geneva: WHO Media Center World Health Organisation (2016) Obesity and overweight. Geneva: WHO Media Center
6.
go back to reference Dżygadło B, Łepecka-Klusek C, Pilewski B (2012) Use of bioelectrical impedance analysis in prevention and treatment of overweight and obesity. Probl Hyg Epidemiol 93(2):274–280 Dżygadło B, Łepecka-Klusek C, Pilewski B (2012) Use of bioelectrical impedance analysis in prevention and treatment of overweight and obesity. Probl Hyg Epidemiol 93(2):274–280
7.
go back to reference Janiszewska R, Orawiec R, Nowak S (2015) Assessment of body composition, total fatness and fatty tissue distribution in women during process of aging. Probl Hyg Epidemiol 96(2):517–522 Janiszewska R, Orawiec R, Nowak S (2015) Assessment of body composition, total fatness and fatty tissue distribution in women during process of aging. Probl Hyg Epidemiol 96(2):517–522
10.
go back to reference Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, Morioka K, Nakatani K, Yano Y, Adachi Y (2003) Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Am Diabetes Assoc 26(8):2341–2344. https://doi.org/10.2337/diacare.26.8.2341CrossRef Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, Morioka K, Nakatani K, Yano Y, Adachi Y (2003) Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Am Diabetes Assoc 26(8):2341–2344. https://​doi.​org/​10.​2337/​diacare.​26.​8.​2341CrossRef
12.
go back to reference Bednarek-Tupikowska G, Stachowska B, Miazgowski T, Krzyżanowska-Świniarska B, Katra B, Jaworski M, Kuliczkowska-Płaksej J, Jokiel- Rokita A, Tupikowska M, Bolanowski M, Jędrzejuk D, Milewicz A (2012) Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population. Endokrynol Polska 63(6):447–455 Bednarek-Tupikowska G, Stachowska B, Miazgowski T, Krzyżanowska-Świniarska B, Katra B, Jaworski M, Kuliczkowska-Płaksej J, Jokiel- Rokita A, Tupikowska M, Bolanowski M, Jędrzejuk D, Milewicz A (2012) Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population. Endokrynol Polska 63(6):447–455
15.
go back to reference Mialich MS, Martinez EZ, Garcia RWD et al (2011) New body mass index adjusted for fat mass (BMIfat) by the use of electrical impedance. Int J Body Compos Res 9(2):65–71 Mialich MS, Martinez EZ, Garcia RWD et al (2011) New body mass index adjusted for fat mass (BMIfat) by the use of electrical impedance. Int J Body Compos Res 9(2):65–71
Metadata
Title
How reliable is BMI? Bioimpedance analysis of body composition in underweight, normal weight, overweight, and obese women
Authors
Agata Lebiedowska
Magdalena Hartman-Petrycka
Barbara Błońska-Fajfrowska
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2021
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-020-02403-3

Other articles of this Issue 3/2021

Irish Journal of Medical Science (1971 -) 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine